Sleeve Lobectomy for Lung Cancer in Minimally Invasive Surgical Techniques
NCT06687408
Summary
The goal of this multicenter observational study is to evaluate the long-term survival and perioperative outcomes of sleeve lobectomy in robotic-assisted thoracic surgery (RATS) for patients with central lung cancer when compared with video-assisted thoracic surgery (VATS) approach, both of which have been already applied to these patients in minimally invasive surgical techniques as part of their regular medical care recently. The main question it aims to answer is: Are RATS sleeve lobectomy associated with similar or even better long-term survival and perioperative outcomes for patients with central lung cancer when compared with the VATS approach?
Eligibility
Inclusion Criteria: * Age ≥ 18 years; * Clinically suspected lung cancer with a high likelihood of undergoing sleeve lobectomy; * Postoperative histopathological diagnosis confirms non-small cell lung cancer (NSCLC); * No history of malignancy within the past 5 years; * Signed informed consent agreeing to participate in this study. Exclusion Criteria: * Unable to undergo surgical resection due to surgical contraindications; * Postoperative pathology does not confirm non-small cell lung cancer (NSCLC), including but not limited to benign lesions, small cell lung cancer, metastatic tumors, or an insufficient or indeterminate histopathology report; * History of malignancy within the past 5 years; * Unable to obtain follow-up data; * Refusal to sign the informed consent or withdrawal of consent.
Conditions3
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06687408